Doxycycline For Treatment Of PD
|
From the research paper:
"The results presented herein reveal potential protective side effects for doxycycline in the pathogenesis cycle of synucleinopathies that could be exploited repurposing an old safe drug." "This data strongly suggests that doxycycline in subantibiotic doses (20–40 mg/day) would be enough to exert neuroprotection." From the ScienceDaily article: "This treatment could stop Parkinson's from progressing, and we therefore plan to start a clinical trial shortly." Could this be another clinical trial worthy of a fast-track process? Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-toxic parallel beta-sheet structured species : Scientific Reports (this is an open-access research paper) |
An impressive piece of biophysics and cell biology.
I think that the comments in the link are worth considering. |
Well spotted, kiwi33. I missed those comments, and they are significant.
It would seem that a fast-tracked clinical trial would not be appropriate. |
Quote:
|
Quote:
|
No worries, Tupelo3.
When I wrote those words, I had in the back of my mind the recent discussions about the desirability of speeding up the clinical-trials phase for PD drugs in general. So it wasn't that this one stood out particularly (although it did seem like a good candidate), it was more that I'd lowered the bar! The question mark at the end was (secret?) code for "I'm interested in a discussion". :-) But after that, kiwi33 alerted me to some expert comments, which shed new light on things. |
Curcumin
From the same paper, curcumin is mentioned. While everyone waits for re-purposed drugs to make it out of these trials, maybe curcumin could help now.
Curcumin (diferuloylmethane) also reduces significantly cell toxicity of α-Syn aggregates by binding to preformed oligomers and fibrils46 with effectiveness comparable with doxycycline (1:1 molar ratio)47. However, the instability, low solubility, little oral bioavailability of curcumin limit its clinical applications and to overcome this drawback, some structural curcumin analogues with antiaggregation properties are been developed. In this context, no human long-term toxicity studies have been reported until now with curcumin structural analogues48. On the contrary, oral administration of doxycycline proved to be a safe and effective drug for dermatologically long-term treatments49,50. Moreover, it was also reported that sub-antibiotic doses of doxycycline have no effect on the composition or antibiotic resistance of different microflora51. |
Quote:
|
I started taking 20 mg a day of Doxy about a week ago. So far, no observable effects.
|
Quote:
I certainly hope your DIY experiment is successful! I have additional thoughts/questions. Please PM me if you have a minute. |
Quote:
Well, you are right about being patient with results. Did you see my post on NTcell and stopping progression? NZ company and they seem to be doing well. |
Quote:
Chronic use of the tetracycline family (minocycline and doxycyline) can trigger pseudotumor cerebri (intracranial hypertension) which can damage the optic nerves. So if you have not had evaluation for this, now is the time to do so. |
Quote:
Thanks! |
Hello PDman
The forum has a default number of posts required before new members can PM Once you reach that, the PM system will open up for you. |
At the rate my PD progression is going, in a year or so I may be dead or in a nursing home for indigent patients, wheel chair bound, stuck in a corner, heavily drugged and drooling. As we know, there aren't many drug options on the table that can potentially slow or stop this progression. I am willing to take a chance on doxycycline. I believe my primary care doc will prescribe it for me. At this stage of the game there's not much for me to lose.
|
Quote:
Sorry not up on Doxycycline so won't comment on it. Blackfeather, maybe you have a bit of depression? Do you see a movement disorder specialist for management of P.D.? If not it might be worthwhile. As far as Drs in general practice go which I think a primary care physician is I'd be more inclined to hear what an MDS who lives and breathes P.D. would come up with plus other medical staff like a speech therapist, physiotherapist, occupational therapist who specialise in P.D. |
Quote:
|
Doxycycline and PD
I'm starting to take 20 mg/day doxycycline, and I'm continuing to discuss the pros and cons of this with my neurologist.
|
Still taking 20 mg/day of doxy, no ill effects observable.
|
Doxycycline 20 mg progress
Quote:
Are you still taking Doxy? Could you give an update please? Thanks! |
Three more months on doxy, still no observable results.
|
Thanks, my eyes are ok. I go to a university medical center and feel I am in good hands. I don't get headaches, thank goodness. I wish I could say I am not "foggy" on a regular basis, but I am. I just posted I have no ill effects from the doxy but didn't mention that I don't see any improvement either. I had long term use of it about 20 years ago when I had Lyme and scleroderma, but that has passed. Or so it seems.
|
To private message I think you click on the name of the person and some choices show up.
:) |
Quote:
I attended the Grand Challenges VAI event in Michigan this week, and asked a panel of PD researchers what they thought of the doxy approach. They were dismissive of it. |
Quote:
|
Quote:
I particularly enjoyed the talks by Langston and Foltynie. |
Quote:
|
All times are GMT -5. The time now is 05:50 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.